GGrantIndex
Sort

326,823 grants matching clinical trial

Rare & Mosaic Disorders - Clinical Research

$1,613,771
Leslie Biesecker · National Human Genome Research Institute · ZIA · FY2022 · HG

A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory Antibodies

$1,613,689
David Allen Wilcox · Medical College Of Wisconsin · R01 · FY2021 · HL

Treatment Efficacy and Toxicity in Rheumatoid Arthritis Database and Repository

$1,613,452
S Louis Bridges · University Of Alabama At Birmingham · RC2 · FY2010 · AR

A trial of transplanting Hepatitis C-viremic kidneys into Hepatitis C-Negative kidney recipients (THINKER-NEXT)

$1,613,436
Peter Philip Reese · University Of Pennsylvania · U01 · FY2023 · DK

Clinical Implementation of Clopidogrel Pharmacogenetics: The TAILOR-PCI Trial - CCC - Lead Application

$1,613,336
Naveen Luke Pereira · Mayo Clinic Rochester · U01 · FY2017 · HL

Admin core

$1,613,332
Wendell A Lim · University Of California, San Francisco · U54 · FY2019 · CA

Immunotherapy with High Frequency, CEA Specific T Cells

$1,613,175
Duke University · P01 · FY2004 · CA

SPORE in GI Cancer

$1,612,852
Robert J Coffey · Vanderbilt University · P50 · FY2013 · CA

Translational center for kidney microphysiological systems to improve drug safety and efficacy

$1,612,823
Jonathan Himmelfarb · Icahn School Of Medicine At Mount Sinai · U2C · FY2025 · TR

In vitro pharmacology, chronic toxicology, and embryo-fetal development studies to demonstrate safety of GSM-779690

$1,612,640
Douglas R Galasko · University Of California, San Diego · U01 · FY2025 · AG

Investigating mechanisms of bladder tumorigenesis and therapeutic resistance

$1,612,616
Abdul Banday · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

Circumventing Barriers to Effective Oncolytic Virotherapy of Malignant Gliomas

$1,612,546
Michael A Caligiuri · Ohio State University · P01 · FY2014 · CA

National Community Oncology Research Project

$1,612,500
Shaker R Dakhil · Via Christi Regional Medical Center · UG1 · FY2016 · CA

SOUTH AFRICA MRC HIV PREVENTION TRIALS UNIT

$1,612,342
Medical Research Council Of South Africa · U01 · FY2001 · AI

CTSA K12 Program at University of California San Diego Altman Clinical and Translational Research Institute

$1,612,278
Colin A Depp · University Of California, San Diego · K12 · FY2025 · TR

Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain

$1,612,143
Ardith Z Doorenbos · University Of Illinois At Chicago · UH3 · FY2021 · AT

Immune Basis & Clinical implications of Threshold-Based Phenotypes of Peanut Allergy

$1,612,047
Maria Cecilia Berin · Icahn School Of Medicine At Mount Sinai · U19 · FY2019 · AI

Vanderbilt Center for Undiagnosed Diseases (VCUD)

$1,612,025
John Atlas Phillips III · Vanderbilt University · U01 · FY2015 · HG

Clinical Interventional Studies of HIV Reservoirs

$1,612,019
Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA

AIDS CLINICAL TRIALS UNIT

$1,611,825
University Of California Los Angeles · U01 · FY2000 · AI

Physicians Health Study II: Prevention Trial of Vitamins

$1,611,803
Brigham And Women'S Hospital · R01 · FY2005 · CA

Eosinophils and Eosinophil Activation in the Pathogenesis of Human Disease

$1,611,737
Amy Klion · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI

Novel Small Molecule Inhibitors of Botulinum Neurotoxin A

$1,611,536
Terry L Bowlin · Microbiotix, Inc · U01 · FY2008 · AI

NIDA IRP Clinical Core support of the NIDA IRP HIV Clinical Program

$1,611,440
Lorenzo Leggio · National Institute On Drug Abuse · ZID · FY2023 · DA

ADULT AIDS CLINICAL TRIALS GROUP

$1,611,440
University Of Alabama At Birmingham · U01 · FY2004 · AI